Skip to content

Drug interactions

Human papillomavirus vaccine + Ibrutinib

Severity: Moderate

Human papillomavirus vaccine and Ibrutinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ibrutinib impairs B-cell function and may reduce the antibody response to HPV vaccine. Protection may be weaker in patients vaccinated during therapy.

What this interaction means in plain words

Human papillomavirus vaccine and Ibrutinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Human papillomavirus vaccine belongs to Miscellaneous; Ibrutinib belongs to Oncology.

Evidence level: Low

Why it happens

Ibrutinib inhibits Bruton tyrosine kinase, reducing B-cell activation and antibody production.

What to do

Complete vaccination before starting ibrutinib when possible; otherwise consider revaccination after therapy ends.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Human papillomavirus vaccine and Ibrutinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Human papillomavirus vaccine with Ibrutinib?

MediHelp rates the interaction as moderate. Human papillomavirus vaccine and Ibrutinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ibrutinib impairs B-cell function and may reduce the antibody response to HPV vaccine. Protection may be weaker in patients vaccinated during therapy.

How serious is the interaction between Human papillomavirus vaccine and Ibrutinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Complete vaccination before starting ibrutinib when possible; otherwise consider revaccination after therapy ends.

What other medicines interact with Human papillomavirus vaccine?

MediHelp also lists interactions of Human papillomavirus vaccine with, for example, Antithymocyte globulin equine, Antithymocyte globulin rabbit, Atidarsagene autotemcel. The full list is on the Human papillomavirus vaccine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in